TROPHY-U-01: Sacituzumab govitecan in patients with mUC after failure of platinum-based regimens or immunotherapy
TROPHY-U-01: Sacituzumab govitecan in patients with mUC after failure of platinum-based regimens or immunotherapy
CARD: Cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resistant prostate cancer
Niraparib therapy in patients with newly diagnosed advanced ovarian cancer
CheckMate 067: Nivolumab plus ipilimumab combination therapy in advanced melanoma
IMspire170: New combination treatment for advanced melanoma
ARIEL3: Rucaparib maintenance treatment for recurrent ovarian carcinoma
Checkmate 227: Final analysis for the non small cell lung cancer trial
PROMISE-meso trial results: Pembrolizumab vs chemotherapy for advanced pleural mesothelioma
KATHERINE trial updates for HER2-positive breast cancer
PARP inhibitors for metastatic breast cancer
Lutetium-177 PSMA scanning for prostate cancer
Highlights from ESMO 2019